Top Story

Israel Cancer Research Fund honors City of Hope provost

Israel Cancer Research Fund honors City of Hope provost
November 29, 2015

Steven T. Rosen, MD, provost and chief scientific officer for City of Hope, received a Lifetime Achievement Award from the Israel Cancer Research Fund.

The award recognizes Rosen’s commitment to advancing science and medicine, as well as providing extraordinary patient care.

Meeting News Coverage

Top Takeaways from ASCO: Prostate cancer screening

November 28, 2015
CHICAGO — The revised guidelines for prostate cancer screening with PSA testing issued by the U.S. Preventive Services Task Force in 2012 reduced the number of…

Lurie Comprehensive Cancer Center names associate director

November 28, 2015
Massimo Cristofanilli, MD, has been appointed associate director for precision medicine and translational research at Robert H. Lurie Comprehensive Cancer Center of…
Meeting News Coverage

Top Takeaways from ASCO: Gynecologic cancers and sexual dysfunction

November 27, 2015
Women with gynecologic cancer demonstrated an increased risk for sexual dysfunction, according to results of a multi-institutional, cross-sectional study.Those who were…
In the Journals

Specialized clinics reduce ED visits among adult survivors of pediatric cancer

November 27, 2015
Survivors of childhood cancers who attend specialized survivor clinics for their long-term care into adulthood are less likely to visit a hospital ED than survivors who…
More News Headlines »

The Patient with Non-Small Cell Lung Cancer

No commercial support for this activity.

The management of non-small cell lung cancer (NSCLC) has evolved in the past decade, as advances are made in diagnosis…
More »
Meeting News Coverage Video

HPV vaccination falling short due to providers, not parents

November 22, 2015
More »

Updates from Vienna 2015 – Highlights in Hematologic Malignancies

This activity is supported by an educational grant from Genentech, Inc.

The management of patients with hematologic malignancies—from diagnosis to treatment decisions—can represent a…
More »
Current Issues
View the Current Issue
HemOnc Today